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ability to determine cost-effectiveness in specific settings.
While site-specific research will likely be necessary, so is
the need to critically evaluate such literature before
blindly using it for decision-making.
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OBJECTIVE: The Benign Prostate Enlargement-Partner
questionnaire (BPE-P) was initially developed to assess
the impact of patient’s Benign Prostatic Hyperplasia
(BPH) on his partner’s quality of life (QOL). The objec-
tive of this study was to adapt the BPE-P for use in the
clinical trial setting, and to linguistically validate the re-
sulting questionnaire in US, Spanish, Canadian English
and Canadian French subjects.
METHODS: The BPE-P was reworded to facilitate use in
a clinical trial, and reviewed by a multidisciplinary team
including clinicians, QOL experts, and linguists. This US
English version was translated according to standard
methodology: 2 forward translations, 1 reconciliation, 1
back-translation by a native English-speaker, 3-4 reviews
by independent bilingual experts, and final reconciliation
by a native-speaking language coordinator. Pilot testing
and cognitive debriefing interviews were performed with
a minimum of 10 subjects per language/country who
were partners of men with BPH.
RESULTS: The following changes were made to the
questionnaire prior to translation: a) recall period of 30
days was incorporated; b) questions were changed to past
tense to reflect the recall period; c) wording on problems
with sex life was changed to sexual satisfaction to better
suit the trial setting and to prevent a response floor effect;
d) responses to the sexual satisfaction and overall QOL
question were revised; e) sexual satisfaction question was
moved to the penultimate item on the scale to better suit
the flow of questions. No significant problems were de-
tected during translation. Subjects found the translations
and their content suitable and relevant to their situation.
The resulting instrument is now called the Benign Prostate
Enlargement-Partner Impact of Treatment scale (BPE-PIT)
to better reflect its adaptation to the clinical trial setting.
CONCLUSION: The BPE-PIT was successfully trans-
lated for use in an international clinical trial. Psychomet-
ric validation of this new instrument remains necessary.
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Urinary problems secondary to benign prostatic hyperpla-
sia (BPH) are found in 20 to 25% of the male population
over 50 years of age. This is thus a public health problem
with a number of diagnostic, therapeutic and economic
facets. The severity of the condition is assessed by the IPSS
score, a well-known and recognized questionnaire.
OBJECTIVE: To evaluate the impact of this male pathol-
ogy on the spouse as part of the growing importance at-
tached to the caregiver.
METHODS: As part of a cohort study conducted be-
tween October 2000 and March 2001, the GP gave the
patient two PFM (Patient Family Measurement) self-
questionnaires for himself and for his spouse. During the
consultation, 36.1% of the patients spontaneously com-
plained of sleep problems.
RESULTS: We are most interested in the impact of day-
time somnolence. The Epworth Scale was used to evaluate
this. The score observed in a control population with nor-
mal sleeping habits is 5.9. For the analysis, we used 482
patient questionnaires and 382 spouse questionnaires. The
rate of return of the spouse questionnaires (80%) was very
satisfactory. The risk of daytime somnolence for the pa-
tient increased with the severity of the urinary problems
with scores of 5.9, 6.4, and 8.9 on the PFM for slight,
moderate, and severe urinary problems respectively. Simi-
larly, for the spouses, the PFM score increased with in-
creasing severity: slight  4.7; moderate  5; severe  7.4.
There is therefore a significant risk of daytime somnolence
among spouses of patients with severe BPH.
CONCLUSION: As it is known that somnolence is re-
sponsible for a third of all road accidents, it is essential
for these patients to limit the severity of their pathology
by undergoing appropriate treatment.
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Urinary problems secondary to benign prostatic hyper-
plasia (BPH) are found in 20 to 25% of the population of
men over 50 years of age. This is therefore a public health
problem with a number of diagnostic, therapeutic and
economic facets. The severity of the problem is assessed
by the score obtained on the IPSS, a well-known and rec-
ognized questionnaire.
OBJECTIVE: As part of the growing importance at-
tached to the caregiver, it is interesting to evaluate the
consequences of this masculine pathology for the spouse.
